[11C]-Methionine-PET/MRI is superior to MRI alone for detecting residual tumor burden in glioblastoma multiforme undergoing radical radiochemotherapy – analysis of a prospective trial

Beuthien-Baumann, B.; Seidlitz, A.; Platzek, I.; Petr, Jan; Kotzerke, J.; Jentsch, Ch.; Löck, S.; Zessin, Jörg; Krex, D.; Zöphel, K.; Schackert, G.; Hoff, Jörg van den; Baumann, M.; Krause, M.

[11C]-Methionine-PET/MRI is superior to MRI alone for detecting residual tumor burden in glioblastoma multiforme undergoing radical radiochemotherapy – analysis of a prospective trial

Beuthien-Baumann, B.; Seidlitz, A.; Platzek, I.; Petr, J.; Kotzerke, J.; Jentsch, C.; Löck, S.; Zessin, J.; Krex, D.; Zöphel, K.; Schackert, G.; van den Hoff, J.; Baumann, M.; Krause, M.

Abstract

kein Abstrakt vorhanden

Keywords: [11C]Methionin; Glioblastoma; Positronen-Emissions-Tomographie

Beteiligte Forschungsanlagen

PET-Zentrum

Abstract in referierter Zeitschrift
European Journal of Nuclear Medicine and Molecular Imaging 45(2018)S1, OP-088
ISSN: 1619-7070

Permalink: https://www.hzdr.de/publications/Publ-28817